Free consultation for international patients
English
WhatsApp [email protected]
Conditions

Lung cancer treatment in China

Lung cancer care in China for international patients, from a free second opinion on your records to treatment at leading cancer and chest hospitals in Beijing and Shanghai.

Lung cancer is the most common cancer in China, so China’s leading cancer and chest hospitals see a very large number of patients with every type and stage of the disease.

Who can ask for a review

Anyone with a diagnosis of lung cancer, or a strong suspicion of it on a scan, can send us their records. That includes people who are newly diagnosed, people whose cancer has come back, and people whose current treatment has stopped working.

Records to send

  • The pathology report from your biopsy or surgery
  • Gene or biomarker test results, if you have them (for example EGFR, ALK, ROS1, PD-L1)
  • Recent CT, PET-CT or brain MRI reports, and the image files if you have them
  • A list of the treatments you have had, with dates and doses

Treatment in China

Standard treatment. Depending on the type and stage, doctors may recommend surgery (often minimally invasive), radiotherapy, chemotherapy, targeted therapy or immunotherapy. These are standard treatments used in China as in other countries.

Medicines developed in China. Lung adenocarcinoma with EGFR mutations is more common in East Asian patients, and several targeted medicines for it were developed in China. Some of them may not be approved in your country. Whether any of them fits your case depends on your test results and the doctors’ assessment.

Clinical trials. Chinese hospitals run many lung cancer trials. Trial treatments are still being studied: they are not standard treatment, and their benefits and risks are not yet fully known.

Hospitals we can arrange

These are examples of hospitals our patients often choose for this condition. We can arrange care at other hospitals too.

We have no formal partnership with these hospitals. Each hospital decides whether to accept a patient and when appointments are available.

From your records to treatment

  1. Free second opinion. Send us your records. Our medical team and specialist doctors in China review them and send you a written opinion, usually within 2 to 4 weeks. See second opinion.
  2. Decide and plan. If you decide to come, we arrange your appointments or admission as soon as possible, together with your visa invitation letter, flights and hotel.
  3. At the hospital. The doctors see you in person, may repeat some tests, and confirm the treatment plan. An interpreter is with you at every appointment.
  4. Back home. You leave with translated reports. We keep you in touch with your doctors in China and help your doctors at home continue your care.

What affects cost and length of stay

We cannot give a fixed price in advance, because it depends on your case. The main factors are:

  • the type and stage of the disease, and the treatment the doctors recommend;
  • which tests the hospital needs to repeat or add;
  • whether you need surgery or a hospital stay, and for how long;
  • the medicines used, and whether you continue treatment in China or at home.

Hospital fees are set by the hospital. Once the doctors have proposed a plan, we ask the hospital for an estimate and share it with you before you decide anything.

Questions patients ask

Do I need gene test results before you can review my case?

No. Send what you have. If gene tests such as EGFR or ALK have not been done, the doctors reviewing your case can tell you whether they are needed.

Can I join a clinical trial in China?

Sometimes. Each trial has its own rules about who can join, and many trials accept only patients who meet strict conditions. We can ask whether a suitable trial is open, but we cannot promise a place.

Will I have to stay in China for all of my treatment?

It depends on the plan. Some patients come for surgery or the start of treatment and continue at home; others stay longer. The doctors decide once they have seen you.

Written by the Overseas Medical Express editorial team. Last reviewed 10 October 2026. General background: National Cancer Institute (US), Lung cancer. This page is general information, not medical advice. Treatment decisions are made by your doctors.